Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SANOFI INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SANOFI INDIA ALKEM LABORATORIES/
SANOFI INDIA
 
P/E (TTM) x 38.0 30.5 124.6% View Chart
P/BV x 6.6 15.2 43.6% View Chart
Dividend Yield % 1.0 7.1 14.0%  

Financials

 ALKEM LABORATORIES   SANOFI INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
SANOFI INDIA
Dec-22
ALKEM LABORATORIES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs3,6257,939 45.7%   
Low Rs2,8355,454 52.0%   
Sales per share (Unadj.) Rs970.11,202.8 80.7%  
Earnings per share (Unadj.) Rs84.2269.5 31.2%  
Cash flow per share (Unadj.) Rs110.2287.7 38.3%  
Dividends per share (Unadj.) Rs50.00570.00 8.8%  
Avg Dividend yield %1.58.5 18.2%  
Book value per share (Unadj.) Rs756.4527.0 143.5%  
Shares outstanding (eoy) m119.5723.03 519.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.35.6 59.8%   
Avg P/E ratio x38.424.9 154.4%  
P/CF ratio (eoy) x29.323.3 125.9%  
Price / Book Value ratio x4.312.7 33.6%  
Dividend payout %59.4211.5 28.1%   
Avg Mkt Cap Rs m386,207154,224 250.4%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3144,059 525.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99327,701 418.7%  
Other income Rs m2,161730 296.0%   
Total revenues Rs m118,15328,431 415.6%   
Gross profit Rs m15,0658,349 180.4%  
Depreciation Rs m3,104419 740.9%   
Interest Rs m1,07417 6,315.3%   
Profit before tax Rs m13,0488,643 151.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9802,437 122.3%   
Profit after tax Rs m10,0686,206 162.2%  
Gross profit margin %13.030.1 43.1%  
Effective tax rate %22.828.2 81.0%   
Net profit margin %8.722.4 38.7%  
BALANCE SHEET DATA
Current assets Rs m86,06436,121 238.3%   
Current liabilities Rs m37,07127,425 135.2%   
Net working cap to sales %42.231.4 134.5%  
Current ratio x2.31.3 176.3%  
Inventory Days Days33117 27.9%  
Debtors Days Days6717 394.4%  
Net fixed assets Rs m37,24512,148 306.6%   
Share capital Rs m239230 104.0%   
"Free" reserves Rs m90,20811,906 757.7%   
Net worth Rs m90,44712,136 745.3%   
Long term debt Rs m00-   
Total assets Rs m124,54148,279 258.0%  
Interest coverage x13.2509.4 2.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 162.3%   
Return on assets %8.912.9 69.4%  
Return on equity %11.151.1 21.8%  
Return on capital %15.671.4 21.9%  
Exports to sales %14.614.1 103.5%   
Imports to sales %014.6 0.0%   
Exports (fob) Rs m16,9163,904 433.3%   
Imports (cif) Rs mNA4,037 0.0%   
Fx inflow Rs m16,9163,904 433.3%   
Fx outflow Rs m4,1904,037 103.8%   
Net fx Rs m12,727-133 -9,587.0%   
CASH FLOW
From Operations Rs m16,8253,987 422.0%  
From Investments Rs m1,1286,509 17.3%  
From Financial Activity Rs m-17,608-15,827 111.3%  
Net Cashflow Rs m416-5,331 -7.8%  

Share Holding

Indian Promoters % 56.7 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 24.4 28.8 84.7%  
FIIs % 8.5 6.3 134.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 39.6 109.2%  
Shareholders   65,184 62,870 103.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Sanofi India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Sanofi India Share Price Performance

Period ALKEM LABORATORIES Sanofi India S&P BSE HEALTHCARE
1-Day 0.16% 0.46% 1.47%
1-Month 0.34% -9.53% -0.47%
1-Year 54.32% 42.18% 62.29%
3-Year CAGR 22.24% 0.43% 18.27%
5-Year CAGR 23.32% 6.73% 19.86%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Sanofi India share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Sanofi India the stake stands at 60.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Sanofi India.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Sanofi India paid Rs 570.0, and its dividend payout ratio stood at 211.5%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Sanofi India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.